IFP Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

IFP Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55K	Sell	165 -475	-74%	-$10.2K	﹤0.01%	3976
2026 Q1	$13.7K	Buy	640 +111	+21%	+$1.56K	﹤0.01%	2994
2025 Q4	$4.93K	Buy	529 +67	+15%	+$560	﹤0.01%	3419
2025 Q3	$3.26K	Buy	462 +404	+697%	+$2.78K	﹤0.01%	3475
2025 Q2	$377	Buy	58 +34	+142%	+$234	﹤0.01%	4501
2025 Q1	$190	Sell	24 -3	-11%	-$32	﹤0.01%	3681
2024 Q4	$342	Buy	27 +3	+13%	+$42	﹤0.01%	3522
2024 Q3	$334	Hold	24	–	–	﹤0.01%	3175
2024 Q2	$331	Hold	24	–	–	﹤0.01%	3115
2024 Q1	$396	Hold	24	–	–	﹤0.01%	2998
2023 Q4	$350	Hold	24	–	–	﹤0.01%	2904
2023 Q3	$294	Buy	+24	New	+$313	﹤0.01%	3158

IFP Advisors's DAWN Position: Q2 2026 in Review

IFP Advisors reduced its Day One Biopharmaceuticals (DAWN) stake by 74% in Q2 2026, selling an estimated $10.2K and leaving 165 shares worth $3.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3976.

IFP Advisors first reported a position in DAWN in Q3 2023 and has held it in 12 quarters since. The position peaked at $13.7K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

IFP Advisors held 165 shares of Day One Biopharmaceuticals worth $3.55K as of Q2 2026.
IFP Advisors sold 475 Day One Biopharmaceuticals shares in Q2 2026, an estimated $10.2K.
Day One Biopharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3976 holding.
IFP Advisors first reported a position in Day One Biopharmaceuticals in Q3 2023 and has held it in 12 quarters since.
IFP Advisors's Day One Biopharmaceuticals position peaked at $13.7K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.